Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELUDYN: Gadopiclenol Injection Parameters in Contrast-enhanced MRI
NCT07346131Phase 4Active, not recruiting
- Sponsor
- Hôpital Fribourgeois
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadopiclenol, sponsored by Hôpital Fribourgeois. Started Jan 2026; status: active, not recruiting.
02
Drugs
gadopiclenol
Beyond the preview
Go deeper on NCT07346131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07346131.